Skip to main content

Find Clinical Trials

Home
Conditions
Hyperlipoproteinemia Type II

Clinical trial condition

Hyperlipoproteinemia Type II

Explore clinical trials studying Hyperlipoproteinemia Type II. Study availability and eligibility vary by location and protocol.

176 public trials 32 recruiting studies

Refine in advanced search Browse all conditions

Hyperlipoproteinemia Type II trial results

Completed

Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects

NCT01412034

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Clinical Research Facility Hartford, Connecticut, United States

Clinical Research Facility North Massapequa, New York, United States

Clinical Research Facility Chicoutimi, Quebec, Canada

Clinical Research Facility Québec, Quebec, Canada

View Trial Details

Completed

Lipid Efficacy/Tolerability Study (0524A-020)

NCT00269204

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Not specified

View Trial Details

Completed

A Study to Assess Any Potential Interaction Between Colesevelam and Ciclosporin in Healthy Volunteers

NCT00692250

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: University Medical Center Groningen- Biotech Center Groningen, Netherlands

View Trial Details

Completed

Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone.

NCT00136981

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Pfizer Investigational Site Hartford, Connecticut, United States

Pfizer Investigational Site Boston, Massachusetts, United States

Pfizer Investigational Site Minneapolis, Minnesota, United States

Pfizer Investigational Site New York, United States

View all 34 locations

View Trial Details

Completed

An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia

NCT01078675

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolaemia, +9 more
Locations: Research Site Cincinnati, Ohio, United States

Research Site Leuven, Belgium

Research Site Leuven, Belgium

Research Site Vancouver, British Columbia, Canada

View all 15 locations

View Trial Details

Completed

Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol

NCT00754039

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Longwood, Florida, United States

Ocala, Florida, United States

Winterpark, Florida, United States

Chicago, Illinois, United States

View Trial Details

Completed

Relationships Between Plasma PCSK9 Levels, LDL-cholesterol Concentrations and Lipoprotein (a) Levels in Familial Hypercholesterolemia

NCT02225340

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
Locations: Institute of Nutrition and Functional Foods (INAF) Québec, Quebec, Canada

View Trial Details

Completed

A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels

NCT01388816

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Genova, Italy

Milan, Italy

Modena, Italy

Palermo, Italy

View Trial Details

Completed

Exploratory Study of Plaque Regression

NCT01515241

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Montreal Heart Institute Montreal, Quebec, Canada

View Trial Details

Completed

A Study of the Safety and Efficacy of Patients With Familial Hypercholesterolaemia Taking Colesevelam as add-on Therapy to Their Existing Medication

NCT00655265

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
Locations: Service d'Endocrinologie, Metabolisme Prevention des Maladies Cardio-Vasculaires Paris, France

Kardiologie Marburg, Germany

Academic Medical Centre Amsterdam, Netherlands

University Medical Centre Nijmegen, Netherlands

View Trial Details